ClinConnect ClinConnect Logo
Search / Trial NCT05079464

Exercise as a Primer for Brain Stimulation in Vascular Cognitive Impairment No Dementia (VCIND)

Launched by SUNNYBROOK HEALTH SCIENCES CENTRE · Oct 12, 2021

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

Transcranial Direct Current Stimulation T Dcs Exercise Cognition Vascular Cognitive Impairment No Dementia Vascular Mild Cognitive Impairment

ClinConnect Summary

This clinical trial is studying how exercise and a technique called transcranial direct current stimulation (tDCS) can help improve memory in people who have vascular cognitive impairment and are at risk for further memory problems. The trial is looking for participants who are at least 50 years old, can exercise at a moderate level, and have some mild memory difficulties. To be eligible, potential participants should also be proficient in English and have certain cardiovascular or cerebrovascular risk factors, but they cannot have a history of stroke or significant psychiatric conditions.

Participants in the trial can expect to engage in exercise sessions and receive brain stimulation treatments to see how these methods affect their memory performance. The trial is currently recruiting individuals who fit the criteria mentioned above. This study aims to better understand how these approaches can work together to help improve cognitive health in individuals at risk for memory decline.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ≥50 years of age; females must be post-menopausal
  • Presence of cerebrovascular and/or cardiovascular risk factors or coronary artery disease
  • Montreal Cognitive Assessment (MoCA) \<27
  • Sufficiently proficient in English
  • Must be able to exercise at a moderate intensity level
  • Presence of modest deficits (1 standard deviation below population norm) in one of the following domains: executive function, verbal memory, working memory, or visuospatial memory
  • Exclusion Criteria:
  • History of stroke
  • Change in psychotropics within the last 4 weeks
  • Current benzodiazepine use due
  • Metal implants that would preclude safe use of tDCS or neuroimaging
  • Significant neurological or psychiatric conditions (current major depressive disorder, bipolar disorder, schizophrenia)
  • MoCA \<18 and/or clinical diagnosis of dementia
  • Any medical contraindications to exercise

About Sunnybrook Health Sciences Centre

Sunnybrook Health Sciences Centre is a leading academic health science organization located in Toronto, Canada, renowned for its commitment to advancing patient care through innovative research and education. As a prominent clinical trial sponsor, Sunnybrook integrates cutting-edge medical research with clinical practice, focusing on a wide range of health disciplines, including cancer care, trauma, and cardiovascular health. The center collaborates with various stakeholders, including academic institutions, healthcare providers, and industry partners, to facilitate the development of novel therapies and improve health outcomes. With a robust infrastructure and a dedicated team of researchers and clinicians, Sunnybrook plays a pivotal role in translating scientific advancements into tangible benefits for patients.

Locations

Toronto, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Krista Lanctôt, PhD

Principal Investigator

Sunnybrook Research Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials